Last updated 2026-06-18
- Raised $500k funding round, Jul 2020
Total raised
$500K
Last: 2020-07
Stage
Pre-Seed
Founded
2008
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
TwoToBiotech's researchers have identified a novel human peptide hormone (P3) thatis expressed in activated immune cells. The company subsequently developed a platform technology with several specific monoclonal antibodies against P3 in order to treat autoimmune diseases. In-vivo studies show that the antibody may be effectivefor treatment of type 1 and type 2 diabetes. TwoToBiotech is developing another novel human peptide hormone, APC1, for treatment of type 2 diabetes. Initial tests on mice have shown promise. The company has also isolated a novel human cardiac peptide that may have the potential tostrongly regulate glucose metabolism.
Funding history · 1 round · $500K total
2020-07
$500K
Q&A
- What is the current operational status of TwoToBiotech?
- TwoToBiotech is currently inactive, having ceased operations in March 2022.
- When was TwoToBiotech founded?
- TwoToBiotech was founded in January 2008.
- What is TwoToBiotech's primary focus in terms of product development?
- TwoToBiotech focuses on developing novel human peptide hormones to treat diabetes, including P3 for type 1 and type 2 diabetes, and APC1 for type 2 diabetes.
- What is the total amount of funding TwoToBiotech has raised?
- TwoToBiotech has raised a total of $500,000.
- When did TwoToBiotech complete its last funding round?
- TwoToBiotech completed its last funding round in July 2020, raising $500,000.
- What is the employee count for TwoToBiotech?
- TwoToBiotech has 1-10 employees.
- Who are the co-founders of TwoToBiotech?
- The co-founders of TwoToBiotech are Orly Devary, who serves as CEO, and Tamara Sandler, who is the Chief Scientist.
- Does TwoToBiotech hold any patents?
- Yes, TwoToBiotech holds 1 patent.
Team · 2
Founder · Co-founder & CEO
Founder · Co-founder & Chief Scientist
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharma-companiesmolecular-biologydiabetespharmaceuticalsautoimmune-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/2619390 |
Identifiers & details
| Founded | 2008-1 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Mar 2022 ceased to operate |